• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV感染者中牛痘和猴痘病毒中和抗体:巴西正痘病毒流行的低收入地区的血清学研究

Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil.

作者信息

Silva Thyago José, Stoffella-Dutra Ana Gabriella, Gripp Victor Lacerda, Gorgens Pollyana R C, Domingos Iago José da Silva, Silva Pedro Henrique Bastos E, Chaves-Garcia Bruna Caroline, Kroon Erna Geessien, Rocha-Vieira Etel, Trindade Giliane de Souza, Oliveira Danilo Bretas de

机构信息

Laboratório de Doenças Infecciosas e Parasitárias, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina 39100-000, Minas Gerais, Brazil.

Laboratório de Vírus, Instituto de Ciências Biológicas, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil.

出版信息

Pathogens. 2025 Jul 25;14(8):733. doi: 10.3390/pathogens14080733.

DOI:10.3390/pathogens14080733
PMID:40872243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12389548/
Abstract

Co-infections of Orthopoxviruses (OPVs), such as vaccinia virus (VACV) and monkeypox virus (MPXV), and the human immunodeficiency virus (HIV) can be associated with severe outcomes. Serro's dairy region, located in Minas Gerais, southeastern Brazil, is an endemic area for VACV, where zoonotic outbreaks affect rural communities. This epidemiological context is especially relevant for at-risk populations, such as people living with HIV (PLHIV). This study aimed to assess the presence of neutralizing antibodies (NAbs) against OPV in PLHIV in this endemic setting. Serum samples were collected from 177 PLHIV in treatment at the specialized service between December 2021 and August 2022. VACV and MPXV NAbs were measured using the plaque reduction neutralization test (PRNT) and VACV-infected cells. The overall occurrence of OPV NAbs was 27.7%. NAbs were higher in individuals born before 1980 (53.3%) than those born after 1980 (1.1%). Among anti-VACV-seropositive individuals, 40.8% also had MPXV NAbs, suggesting cross-immunity. These findings indicate the circulation of VACV in PLHIV and highlight the increased susceptibility to OPV infections among individuals born after the cessation of smallpox vaccination. The results reinforce the importance of continued surveillance of OPV, especially in endemic regions and vulnerable populations.

摘要

正痘病毒(OPV)的合并感染,如牛痘病毒(VACV)和猴痘病毒(MPXV),与人免疫缺陷病毒(HIV)合并感染可能会导致严重后果。位于巴西东南部米纳斯吉拉斯州的塞罗乳制品区是VACV的流行地区,人畜共患疫情影响农村社区。这种流行病学背景对于高危人群,如艾滋病毒感染者(PLHIV)尤为重要。本研究旨在评估在这一流行地区的PLHIV中针对OPV的中和抗体(NAbs)的存在情况。2021年12月至2022年8月期间,从专业服务机构接受治疗的177名PLHIV中采集血清样本。使用蚀斑减少中和试验(PRNT)和感染VACV的细胞测量VACV和MPXV NAbs。OPV NAbs的总体发生率为27.7%。1980年以前出生的个体(53.3%)的NAbs高于1980年以后出生的个体(1.1%)。在抗VACV血清阳性个体中,40.8%也有MPXV NAbs,提示存在交叉免疫。这些发现表明VACV在PLHIV中传播,并突出了天花疫苗接种停止后出生的个体对OPV感染易感性增加。结果强化了持续监测OPV的重要性,尤其是在流行地区和弱势群体中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/12389548/bc5049a6f9aa/pathogens-14-00733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/12389548/d82473538d74/pathogens-14-00733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/12389548/bc5049a6f9aa/pathogens-14-00733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/12389548/d82473538d74/pathogens-14-00733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/12389548/bc5049a6f9aa/pathogens-14-00733-g002.jpg

相似文献

1
Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil.HIV感染者中牛痘和猴痘病毒中和抗体:巴西正痘病毒流行的低收入地区的血清学研究
Pathogens. 2025 Jul 25;14(8):733. doi: 10.3390/pathogens14080733.
2
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination.在天花疫苗接种前后,用于评估猴痘病毒和牛痘病毒抗体的微量中和试验与多重免疫测定之间的相关性。
Front Immunol. 2025 Jun 23;16:1585284. doi: 10.3389/fimmu.2025.1585284. eCollection 2025.
3
Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study.天花疫苗接种前后猴痘病毒和牛痘病毒中和抗体的评估:血清流行病学研究。
J Med Virol. 2024 Jun;96(6):e29728. doi: 10.1002/jmv.29728.
4
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines.感染猴痘病毒(MPXV)或接种安卡拉痘苗病毒(modified vaccinia Ankara)疫苗的个体对MPXV免疫的特征分析与比较
J Immunol. 2025 Feb 1;214(2):211-222. doi: 10.1093/jimmun/vkae031.
5
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study.正痘病毒疫苗接种和猴痘感染对交叉保护性免疫的影响:一项多队列观察性研究。
Lancet Microbe. 2025 Apr 28:101098. doi: 10.1016/j.lanmic.2025.101098.
6
Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay.猴痘病毒H3L蛋白作为开发中和抗体及血清学检测的靶抗原。
Appl Microbiol Biotechnol. 2025 Apr 2;109(1):80. doi: 10.1007/s00253-025-13466-6.
7
Exploring monkeypox virus antibody levels: insights from human immunological research.探索猴痘病毒抗体水平:来自人体免疫学研究的见解
Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0.
8
Multiple gene-deletion vaccinia virus Tiantan strain against mpox.针对猴痘的多基因缺失痘苗病毒天坛株
Virol J. 2025 Jan 25;22(1):17. doi: 10.1186/s12985-025-02629-6.
9
A bivalent Mpox nanoparticle vaccine induces robust immune response and provides long-lasting protection against vaccinia virus challenge.一种二价猴痘纳米颗粒疫苗可诱导强烈的免疫反应,并对痘苗病毒攻击提供持久保护。
Emerg Microbes Infect. 2025 Dec;14(1):2535485. doi: 10.1080/22221751.2025.2535485. Epub 2025 Jul 28.
10
Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay.在MSD免疫测定中,使用MPXV和VACV抗原对的比例对自然获得的猴痘和MVA-BN疫苗诱导的抗体反应进行血清学区分。
Microbiol Spectr. 2025 Aug 8:e0018225. doi: 10.1128/spectrum.00182-25.

本文引用的文献

1
Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study.根据 HIV 状况和历史上的天花疫苗接种情况比较针对猴痘病毒的抗体水平:血清学研究。
Emerg Microbes Infect. 2024 Dec;13(1):2356153. doi: 10.1080/22221751.2024.2356153. Epub 2024 May 29.
2
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II.天花疫苗接种所引发的抗体可交叉中和2022年猴痘病毒进化枝II。
J Med Virol. 2023 Mar;95(3):e28643. doi: 10.1002/jmv.28643.
3
Mpox in people with advanced HIV infection: a global case series.
晚期HIV感染者中的猴痘:一项全球病例系列研究。
Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21.
4
Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.2022 年 8 月 10 日至 10 月 10 日,美国住院患者中的严重猴痘病例。
MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412-1417. doi: 10.15585/mmwr.mm7144e1.
5
Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia.HIV/AIDS 患者经动物源性传播获得的进行性牛痘
Emerg Infect Dis. 2020 Mar;26(3):601-605. doi: 10.3201/eid2603.191365.
6
Vaccinia Virus among Domestic Dogs and Wild Coatis, Brazil, 2013-2015.巴西 2013-2015 年家养犬和浣熊痘病毒。
Emerg Infect Dis. 2018 Dec;24(12):2338-2342. doi: 10.3201/eid2412.171584.
7
Cross-sectional study involving healthcare professionals in a Vaccinia virus endemic area.一项涉及痘苗病毒流行地区医护人员的横断面研究。
Vaccine. 2017 Jun 5;35(25):3281-3285. doi: 10.1016/j.vaccine.2017.04.048. Epub 2017 May 8.
8
Natural Vaccinia Virus Infection: Diagnosis, Isolation, and Characterization.天然痘苗病毒感染:诊断、分离与鉴定
Curr Protoc Microbiol. 2016 Aug 12;42:14A.5.1-14A.5.43. doi: 10.1002/cpmc.13.
9
Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV.巴西农村地区正痘病毒血清流行率:了解抗正痘病毒疫苗免疫状况及其对新发人畜共患正痘病毒的影响。
Virol J. 2016 Jul 4;13:121. doi: 10.1186/s12985-016-0575-6.
10
Smallpox vaccines: targets of protective immunity.天花疫苗:保护性免疫的靶标。
Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x.